Medplus Health Services Limited (NSE: MEDPLUS), ISIN INE804L01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MEDPLUS last traded at ₹721.20 (+2.96%), with a 52-week range of ₹653.80 to ₹1020.35 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 40.19%, FIIs 14.38%, DIIs 29.95%, mutual funds 24.51%.
EquiSense Score (ECS): 59/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.